Xilio Therapeutics Inc (XLO) Volatility Spurs A Quest For Clarity
Currently, there are 51.78M common shares owned by the public and among those 15.84M shares have been available to trade. The company’s stock has a 5-day price change of -1.19% and 9.10% over the past three months. XLO shares are trading -23.46% year to date (YTD), with the 12-month market performance down to -39.59% lower. […]
